Fundraising Fox

SignalRX Pharmaceuticals

Cumming, US · Delaware corporation

Founders & leadership

MW
Matthew WilliamsDirector and Chief Executive Officer
GM
Guillermo MoralesNamed on SEC filing
JW
Joel WernickNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$250K disclosed across 1 round · 2022

$250KraisedMay 2023 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Guillermo MoralesDirector
  • Joel WernickDirector
  • Matthew WilliamsExecutive Officer, Director
Offering amount
$485K
Amount sold
$250K
Minimum investment
$25K
First sale
Sep 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with SignalRX Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 5 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2019$299.9K
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2018$299.7K
National Institutes of Health (NIH)National Institutes of HealthPhase IISTTR2017$2M
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2016$299.7K
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2015$209K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

How much funding has SignalRX Pharmaceuticals raised?
SignalRX Pharmaceuticals has disclosed $250K raised across 1 round.
Where is SignalRX Pharmaceuticals headquartered?
SignalRX Pharmaceuticals is headquartered in Cumming, US.